Featured news
-
Clinician webinar: Circulating Tumour DNA project
In support of the national roll-out of ctDNA testing to a further 10,000 patients, we are running two identical 30 minute sessions on Monday 29 April, and Thursday 2 May 2024, to share with healthcare staff the pathway, supporting resources/documentation and information on the testing process including how to order testing kits.
-
Blood test reveals best lung cancer treatment
Thousands of patients in England with suspected lung cancer are being offered a blood test which can show if they can get early access to targeted therapies.
-
Next generation genomic testing brings benefits to patients and clinicians at NUH
Genomic testing is an important tool in the diagnosis of many rare conditions and cancers. But when it comes to cancer, it can also help to understand a patient’s prognosis, for example how quickly their cancer is likely to grow. However, perhaps most importantly for most cancer patients, gene variants revealed through genomic testing can also help doctors provide more effective treatments, with potentially fewer side-effects, via targeted therapies.
-
Genomics BITE: Pharmacogenomic testing prior to aminoglycoside use
Our series of regular Genomics BITE sessions provide healthcare staff with updates, information and training on key areas of genomic medicine and testing.
-
Lynch Syndrome Awareness Day: 22 March 2024
Lynch Syndrome Awareness Day in 2024 is Friday 22 March. You can read some clinician and patient stories on this page which shed light on this common genetic condition.
-
Introducing our new Cancer Lead for the East Midlands
We're delighted to welcome Professor Srinivasan Madhusudan who joins us as Cancer Lead for the East Midlands.
All news
Showing 20 results
Milestone reached in pioneering brain cancer trial
More than 140 brain cancer patients have benefitted from a landmark NHS testing and treatment programme being trialled at Addenbrooke's, using the latest innovations in genomics and cancer research.
Rory's story: finding answers by genetic testing
Little Rory Cross is one of only 14 people in the world with Chitayat syndrome, a very rare genetic disease diagnosed only after genome sequencing.
Genomics study diagnoses thousands of children with rare disorders
An Addenbrooke’s consultant is playing a key role in a UK study, revealing genetic causes for rare developmental disorders in 5,500 children and helping to improve diagnosis worldwide.
Register your free place for our Genomics Showcase event in May
Registration is now OPEN for our Genomics Showcase on Thursday 4 May 2023 in Peterborough.
The SWAN and the diagnostic odyssey: how whole genome sequencing brought one family answers to decade-long questions
From the moment Sasha was born at home in Nottingham, her parents Lisa and Mat Gapp where aware that their first child had some differences.
Blood cancer manipulates immune cells to survive
The most comprehensive study to date of the blood cancer, Hodgkin lymphoma, has provided fascinating insights into what tumour cells must do to survive.
CamRARE promotes diagnostic equity for all for Rare Disease Day
Originally published in the Cambridge Independent.
Newly developed genetic testing of tumours could mean ‘gift of life’ for family members
“It came out of a clear blue sky” recalls Andy. “It was ridiculous. I was such a fit guy. I’d done the Leicester marathon just a few weeks before”.
Genomic testing capability ramps up at Leicester Laboratory
NHS East Genomics has increased its genomic testing capacity across the East of England and East Midlands by enabling its Leicester laboratory to carry out urgent cancer testing on site.
New genetic testing clinic for children with hearing loss
A new clinic at Addenbrooke's is using genetic testing to help improve the treatment and care of children with hearing loss.
Whole genome sequencing reveals novel non cancerous tumour mutation
Genomic testing on a young child’s growing tumour proved it to be benign after traditional laboratory methods were unable to give a firm diagnosis. The sequencing analysis has led to the discovery of a new gene mutation which will help in the diagnosis of future patients with similar tumours.
Festival of Genomics and Biodata 2023
An annual get-together for the entire genomics and biodata community, to discover, meet, learn and celebrate. This year’s Festival promises inspirational speakers, the latest research and clinical breakthroughs, cutting-edge technology and incredible networking opportunities.
New Year Honours for Cambridge clinicians
Two New Year Honours have been awarded to clinicians at Cambridge University Hospitals NHS Foundation Trust who are known for their work in genomics.
Cystic Renal Disease: Genomics Workshops
We are running a series of online workshops from March 2023 on Cystic Renal Disease, to get views on a model of nursing practice that enables equitable access and delivery of genomic care for patients with Cystic Renal Disease.
The 12 (Genomic) Days of Christmas - short animation from NHS East Genomics
A little animation based on The 12 Days of Christmas to introduce you to NHS East Genomics, with some facts and figures and a cameo or two from a certain hirsute, jolly gentleman...
Millions pledged for newborn genetic testing
The government has announced £105 million in funding to speed up diagnosis of rare genetic diseases in newborns, potentially resulting in life-saving interventions for thousands of babies.
Play Domino Talk Health events tackle prostate cancer health inequalities
Members of the local Afro-Caribbean community were invited to a Church in the St. Anne’s area of Nottingham on Monday 5 December to take part in a Play Domino Talk Prostate event run by our United Against Prostate Cancer (UAPC) project team.
Call for wider genetic testing for children with brain tumours
A team of doctors at Addenbrooke’s have highlighted how a simple genetic screening test improved the diagnosis and treatment of a little 17-month old girl with a brain tumour – caused by a rare condition.
RAREfest 2022 at Cambrdige Guildhall Saturday 26 November
Will we see you there?
Public consultation on clinical genomics services in England
Consultation period update